BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31037767)

  • 21. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
    Yang L; Feng S; Yang Y
    Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework.
    Hussein R; Abou-Shanab AM; Badr E
    NPJ Syst Biol Appl; 2024 May; 10(1):52. PubMed ID: 38760476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
    Jiang P; Sun W; Shen N; Huang X; Fu S
    BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weighted gene co-expression network analysis in identification of endometrial cancer prognosis markers.
    Zhu XL; Ai ZH; Wang J; Xu YL; Teng YC
    Asian Pac J Cancer Prev; 2012; 13(9):4607-11. PubMed ID: 23167388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
    Chen B; Gao S; Ji C; Song G
    Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
    Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
    Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the Ferroptosis-Associated Gene Signature to Predict the Prognostic Status of Endometrial Carcinoma Patients.
    Qin J; Shao X; Wu L; Du H
    Comput Math Methods Med; 2021; 2021():9954370. PubMed ID: 34531924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-1 Coexpression Gene Analysis and the Regulatory Network in Endometrial Cancer Based on Bioinformatics Analysis.
    Wang L; Liu Z; Zhang W; Zhang A; Qu P
    Biomed Res Int; 2021; 2021():9923434. PubMed ID: 34124265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
    Qiu X; Gao Z; Shao J; Li H
    Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.
    Liu A; Zhang D; Yang X; Song Y
    J Cell Biochem; 2019 Oct; 120(10):17593-17601. PubMed ID: 31140648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
    Liang Y; Zhang C; Dai DQ
    World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.